sample,fastq_1,fastq_2,fasta,run_accession,experiment_accession,sample_accession,secondary_sample_accession,study_accession,secondary_study_accession,submission_accession,run_alias,experiment_alias,sample_alias,study_alias,library_layout,library_selection,library_source,library_strategy,library_name,instrument_model,instrument_platform,base_count,read_count,tax_id,scientific_name,sample_title,experiment_title,study_title,sample_description,fastq_md5,fastq_bytes,fastq_ftp,fastq_galaxy,fastq_aspera
SRX122150,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX122150_SRR413772_1.fastq.gz,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX122150_SRR413772_2.fastq.gz,,SRR413772,SRX122150,SAMN00792117,SRS295028,PRJNA422434,SRP008047,SRA050230,BGI-T2D-97A-FCC02W4ACXX-3,bgi-T2D-97A-SZAXPI000913-113,bgi-T2D-97A,BGI_T2D,PAIRED,RANDOM,METAGENOMIC,WGS,SZAXPI000913,Illumina Genome Analyzer II,ILLUMINA,4377366360,24318702,408170,human gut metagenome,T2D metagenomics,Illumina Genome Analyzer II paired end sequencing: A Metagenome-Wide Association Study of gut microbiota identifies markers associated with Type 2 Diabetes,A metagenome-wide association study of gut microbiota in type 2 diabetes.,A Metagenome-Wide Association Study of gut microbiota identifies markers associated with Type 2 Diabetes based on next generation sequencing technology,4b86a79ce15ccb923fde26b532c4851c;fd7882f2379224c8adfe65dd8220d7b4,988020128;987855249,ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413772/SRR413772_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413772/SRR413772_2.fastq.gz,ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413772/SRR413772_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413772/SRR413772_2.fastq.gz,fasp.sra.ebi.ac.uk:/vol1/fastq/SRR413/SRR413772/SRR413772_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR413/SRR413772/SRR413772_2.fastq.gz
SRX122151,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX122151_SRR413773_1.fastq.gz,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX122151_SRR413773_2.fastq.gz,,SRR413773,SRX122151,SAMN00792118,SRS295029,PRJNA422434,SRP008047,SRA050230,BGI-T2D-9A-FCD05PKACXX-2,bgi-T2D-9A-SZAXPI000839-102,bgi-T2D-9A,BGI_T2D,PAIRED,RANDOM,METAGENOMIC,WGS,SZAXPI000839,Illumina Genome Analyzer II,ILLUMINA,5618882160,31216012,408170,human gut metagenome,T2D metagenomics,Illumina Genome Analyzer II paired end sequencing: A Metagenome-Wide Association Study of gut microbiota identifies markers associated with Type 2 Diabetes,A metagenome-wide association study of gut microbiota in type 2 diabetes.,A Metagenome-Wide Association Study of gut microbiota identifies markers associated with Type 2 Diabetes based on next generation sequencing technology,3b3f89b2aaec13fb7ea4c135b79e87c4;3df73b81bd98111935f3780b8dd03ba1,1264110866;1263994760,ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413773/SRR413773_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413773/SRR413773_2.fastq.gz,ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413773/SRR413773_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR413/SRR413773/SRR413773_2.fastq.gz,fasp.sra.ebi.ac.uk:/vol1/fastq/SRR413/SRR413773/SRR413773_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR413/SRR413773/SRR413773_2.fastq.gz
SRX4954910,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX4954910_SRR8133837_1.fastq.gz,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX4954910_SRR8133837_2.fastq.gz,,SRR8133837,SRX4954910,SAMN10342721,SRS3996286,PRJNA499081,SRP167218,SRA800639,9_1_FF2_08_DNA_GCTACGCT-GCGTAAGA_L002_R1_001.fastq,R3.1,9_1_FF2_08_DNA_GCTACGCT-GCGTAAGA_L002,PRJNA499081,PAIRED,RANDOM,METAGENOMIC,WGS,R3.1,Illumina HiSeq 2500,ILLUMINA,1103106210,2213143,408170,human gut metagenome,R3_1,Illumina HiSeq 2500 sequencing: R3.1-R1,Gut bacteriophage community of metabolic syndrome subjects during fecal microbial transplant,R3_1,cffc5ddb11a01bfb61c9ddc52fa88f73;36116103cd23708b0c8d395037885cc4,373579814;417655601,ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_2.fastq.gz,ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_2.fastq.gz,fasp.sra.ebi.ac.uk:/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR813/007/SRR8133837/SRR8133837_2.fastq.gz
SRX4954909,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX4954909_SRR8133838_1.fastq.gz,https://github.com/tanaes/nf-reads-profiler/raw/multi-sample/assets/test_data/SRX4954909_SRR8133838_2.fastq.gz,,SRR8133838,SRX4954909,SAMN10342716,SRS3996285,PRJNA499081,SRP167218,SRA800639,5_ACTCGCTA-CTCTCTAT_L002_R1_001.fastq,R3.2,5_ACTCGCTA-CTCTCTAT_L002,PRJNA499081,PAIRED,RANDOM,METAGENOMIC,WGS,R3.2,Illumina HiSeq 2500,ILLUMINA,1268856346,2610191,408170,human gut metagenome,R3_2,Illumina HiSeq 2500 sequencing: R3.2-R1,Gut bacteriophage community of metabolic syndrome subjects during fecal microbial transplant,R3_2,068a7c2e93ddec997b4d53364d66e8a6;cdaeec0cb9e4d4a085d6f8152c86c456,421385163;462058767,ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_2.fastq.gz,ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_1.fastq.gz;ftp.sra.ebi.ac.uk/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_2.fastq.gz,fasp.sra.ebi.ac.uk:/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_1.fastq.gz;fasp.sra.ebi.ac.uk:/vol1/fastq/SRR813/008/SRR8133838/SRR8133838_2.fastq.gz